Innovative 3D Bioprinting Advances Tissue Engineering in ASEAN

A Breakthrough in 3D Bioprinting for Tissue Engineering \nResearchers from the University of Notre Dame and Harvard Medical School have developed a novel 3D bioprinting method that can create vascular networks at the capillary scale. This breakthrough, published in *Nature Chemical Engineering*, addresses a critical challenge in tissue engineering: how to build fine vascular networks that keep cells alive in larger constructs. The implications for factories in Thailand, Vietnam, Indonesia, and Malaysia are significant, as this technology could enhance the production of advanced medical devices and pharmaceuticals.\n \\[---]\\[---]\\\\\\n## Hybrid Printing System Combines Extrusion and Aerosol Jet Printing \\[---]\\\\\\nThe researchers designed a custom system that integrates extrusion bioprinting, which is suitable for larger structures, with aerosol jet printing, which can produce extremely fine channels. This hybrid approach allows for the creation of channels as small as 5-6 microns, comparable to the size of human capillaries. The ability to adjust channel size and geometry during printing enables the formation of complex, hierarchical networks that closely mimic natural vasculature. For ASEAN factories, this means the potential to produce more sophisticated and functional tissue constructs, which could be used in drug testing and disease modeling.\\\\n \\[---]\\[---]\\\\\\n## Machine Learning Enhances Precision and Efficiency \\[---]\\\\\\nThe system also incorporates machine learning, specifically Bayesian optimization, to streamline the calibration process. This reduces the need for extensive trial and error, allowing the team to quickly identify the optimal printing parameters for different channel sizes. In laboratory tests, the printed vascular networks supported the attachment and growth of endothelial cells, which form the lining of blood vessels. The successful integration of these cells and the ability to maintain cell viability within the printed structures are crucial steps toward clinical applications. For ASEAN manufacturers, this could mean faster and more efficient development of new medical products, potentially reducing time-to-market and costs.\\\\n \\[---]\\[---]\\\\\\n## Potential Applications and Future Prospects \\[---]\\\\\\nThe research is part of a broader project funded by the National Institutes of Health (NIH) aimed at developing vascularized tissues that can function on a larger scale. The immediate applications include drug testing and disease modeling, where vascularized tissue constructs can provide more realistic conditions for studying human diseases and evaluating new therapies. In the longer term, the goal is to advance toward the fabrication of larger engineered tissues and, eventually, organs. For ASEAN factories, this opens up opportunities in the medical and pharmaceutical sectors, where the demand for advanced, biologically relevant models is growing.\\\\n \\[---]\\[---]\\\\\\n## Conclusion \\[---]\\\\\\nThis innovative 3D bioprinting technique represents a significant step forward in tissue engineering. For factories in Thailand, Vietnam, Indonesia, and Malaysia, it offers the potential to develop more advanced and clinically relevant tissue constructs. As the technology matures, it could lead to the production of more sophisticated medical devices and pharmaceuticals, enhancing the competitiveness of ASEAN's manufacturing sector in the global market. Factory buyers should consider investing in this technology to stay at the forefront of innovation and meet the growing demand for advanced medical solutions.\\\\n